Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Clinical trial NCT00595920 · TERMINATED

Trial details

NCT number: NCT00595920
Sponsor: Opexa Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Clinically Isolated Syndrome

Start date: 2007-11-01
Primary completion: 2008-12-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.